AR213172A1 - Nuevos compuestos derivados de la dl-omega-carboalcoxi(c1-c7)-hexil-5-(3'-hidroxi-u-oxo-1'octen-(e)-il)-2-pirrolidinona,desprovistos de actividad terapeutica y particularmente utiles como intermediarios en la sintesis de derivados de prostaglandina,tales como la dl-8-aza-11-deoxi-pge,procedimiento para elaborar dicha prostagiandina y procedimiento para preparar los referidos intermediarios - Google Patents

Nuevos compuestos derivados de la dl-omega-carboalcoxi(c1-c7)-hexil-5-(3'-hidroxi-u-oxo-1'octen-(e)-il)-2-pirrolidinona,desprovistos de actividad terapeutica y particularmente utiles como intermediarios en la sintesis de derivados de prostaglandina,tales como la dl-8-aza-11-deoxi-pge,procedimiento para elaborar dicha prostagiandina y procedimiento para preparar los referidos intermediarios

Info

Publication number
AR213172A1
AR213172A1 AR262630A AR26263076A AR213172A1 AR 213172 A1 AR213172 A1 AR 213172A1 AR 262630 A AR262630 A AR 262630A AR 26263076 A AR26263076 A AR 26263076A AR 213172 A1 AR213172 A1 AR 213172A1
Authority
AR
Argentina
Prior art keywords
prepare
procedure
prostagiandine
poorers
carboalcoxi
Prior art date
Application number
AR262630A
Other languages
English (en)
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Application granted granted Critical
Publication of AR213172A1 publication Critical patent/AR213172A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/16Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AR262630A 1975-03-21 1976-03-19 Nuevos compuestos derivados de la dl-omega-carboalcoxi(c1-c7)-hexil-5-(3'-hidroxi-u-oxo-1'octen-(e)-il)-2-pirrolidinona,desprovistos de actividad terapeutica y particularmente utiles como intermediarios en la sintesis de derivados de prostaglandina,tales como la dl-8-aza-11-deoxi-pge,procedimiento para elaborar dicha prostagiandina y procedimiento para preparar los referidos intermediarios AR213172A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB12034/75A GB1529852A (en) 1975-03-21 1975-03-21 8-azaprostaglandins and process for the preparation thereof

Publications (1)

Publication Number Publication Date
AR213172A1 true AR213172A1 (es) 1978-12-29

Family

ID=9997230

Family Applications (1)

Application Number Title Priority Date Filing Date
AR262630A AR213172A1 (es) 1975-03-21 1976-03-19 Nuevos compuestos derivados de la dl-omega-carboalcoxi(c1-c7)-hexil-5-(3'-hidroxi-u-oxo-1'octen-(e)-il)-2-pirrolidinona,desprovistos de actividad terapeutica y particularmente utiles como intermediarios en la sintesis de derivados de prostaglandina,tales como la dl-8-aza-11-deoxi-pge,procedimiento para elaborar dicha prostagiandina y procedimiento para preparar los referidos intermediarios

Country Status (26)

Country Link
JP (1) JPS607602B2 (es)
AR (1) AR213172A1 (es)
AT (1) AT348163B (es)
AU (1) AU501105B2 (es)
BE (1) BE839761A (es)
CA (1) CA1076587A (es)
CH (2) CH611881A5 (es)
DE (1) DE2612114A1 (es)
DK (1) DK140937B (es)
ES (2) ES446239A1 (es)
FI (1) FI61692C (es)
FR (1) FR2304340A1 (es)
GB (1) GB1529852A (es)
HU (1) HU173348B (es)
IE (1) IE42966B1 (es)
IT (1) IT1061011B (es)
MX (1) MX3301E (es)
NL (1) NL7602891A (es)
NO (1) NO144147C (es)
NZ (1) NZ180251A (es)
OA (1) OA05279A (es)
PT (1) PT64919B (es)
SE (1) SE418290B (es)
SU (1) SU614746A3 (es)
YU (1) YU73876A (es)
ZA (1) ZA761448B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
US5540618A (en) * 1994-10-28 1996-07-30 National University Of Singapore Passive attenuator for shelter protection against explosions
CA2477715A1 (en) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient

Also Published As

Publication number Publication date
IE42966L (en) 1976-09-21
IE42966B1 (en) 1980-11-19
ATA195676A (de) 1978-06-15
BE839761A (fr) 1976-09-20
NO144147C (no) 1981-07-15
ES446239A1 (es) 1977-07-01
SU614746A3 (ru) 1978-07-05
NO760994L (es) 1976-09-22
DK140937B (da) 1979-12-10
AT348163B (de) 1979-02-12
GB1529852A (en) 1978-10-25
DK88276A (es) 1976-09-22
AU501105B2 (en) 1979-06-14
PT64919B (en) 1977-08-24
FR2304340A1 (fr) 1976-10-15
PT64919A (en) 1976-04-01
OA05279A (fr) 1981-02-28
JPS51138671A (en) 1976-11-30
MX3301E (es) 1980-09-03
DK140937C (es) 1980-05-19
FI760744A (es) 1976-09-22
FR2304340B1 (es) 1979-06-29
FI61692B (fi) 1982-05-31
NZ180251A (en) 1978-07-28
SE7603400L (sv) 1976-09-22
ZA761448B (en) 1977-03-30
DE2612114A1 (de) 1976-10-07
YU73876A (en) 1982-10-31
CH611881A5 (en) 1979-06-29
JPS607602B2 (ja) 1985-02-26
CH611604A5 (en) 1979-06-15
FI61692C (fi) 1982-09-10
ES458389A1 (es) 1978-02-16
NL7602891A (nl) 1976-09-23
SE418290B (sv) 1981-05-18
IT1061011B (it) 1982-10-20
AU1189976A (en) 1977-09-15
NO144147B (no) 1981-03-23
CA1076587A (en) 1980-04-29
HU173348B (hu) 1979-04-28

Similar Documents

Publication Publication Date Title
MX4018E (es) Procedimiento para la preparacion de derivados substituidos del acido n-(alfa-fenil-bencilidenil)-amino-alcanoico
MX4584E (es) Procedimiento para la preparacion de los compuestos 2-fenil-3-aroil-benzotiofeno
AR208414A1 (es) Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
AR212515A1 (es) Procedimiento para preparar nuevos derivados del(piperidil-4 alquil)-3 indol
MX5582E (es) Procedimiento para preparar derivados del acido 1,2,3-tiadiazola-5-carboxilico
MX4282E (es) Procedimiento mejorado para la estabilizacion termica de la n-metil-2-pirrolidona
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
AR217577A1 (es) Procedimiento para la preparacion de 6,7-dialcoxi-1-piperidinoftalazinas utiles como agentes terapeuticos
AR221221A1 (es) Procedimiento para reducir la concentracion de nitrosaminas
AR225727A1 (es) Procedimiento para la obtencion de nuevos derivados de interfennilen-8-aza-9-dioxotia-11,12-seco-prostaglandina
AR213172A1 (es) Nuevos compuestos derivados de la dl-omega-carboalcoxi(c1-c7)-hexil-5-(3'-hidroxi-u-oxo-1'octen-(e)-il)-2-pirrolidinona,desprovistos de actividad terapeutica y particularmente utiles como intermediarios en la sintesis de derivados de prostaglandina,tales como la dl-8-aza-11-deoxi-pge,procedimiento para elaborar dicha prostagiandina y procedimiento para preparar los referidos intermediarios
MX3580E (es) Procedimiento para la preparacion de benzamidas substituidas
ES528066A0 (es) Procedimiento para preparar nuevos derivados del azabiciclo heptano.
AR217335A1 (es) Procedimiento para preparar derivados de la 2,6-difenil-3,7-dioxabiciclo-(3,3,0)-octano-4,8-diona
IT1107027B (it) Procedimento per la preparazione del percarbonato sodico
AR211926A1 (es) Derivados de cis-3-aminometil-2-fenil-biciclo-2,2,2-octano desprovistos de actividad terapeutica,utiles como intermediarios para preparar productos terapeuticos
MX5624E (es) Procedimiento para la preparacion de alcaloides del tipo de leurosina
MX5469E (es) Procedimiento para la preparacion de n-(4-pirazolidinil)benzamidas
MX3519E (es) Procedimiento para la preparacion de n-(1-etil-2-pirrolidilmetil)-2-metoxi-5-sulfamoil benzamida
AR215869A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-fenil-2-aminoetanol
AR212328A1 (es) Procedimiento para preparar analogos de 16-alcoxi y 16-fenoxi prostaglandina
AR212638A1 (es) Nuevos compuestos intermediarios,desprovistos de accion terapeutica y constituidos por 6-trifenilamino-2,2-dimetil-3-acetil-e-hidroxi-penamsy procedimiento para su preparacion
AR220130A1 (es) Procedimiento para la sintesis de s-triacinas fluoradas
ES487661A0 (es) Procedimiento para la obtencion de nuevos derivados de 4,7- fenantrolina